Table 3.
Expression profiling of the M. anisopliae cluster related to the biosynthesis of a helvolic acid compound
| NCBI gene locus ID | Expression (RPKM) | Differential expression (log2-fold change) | Gene product | |||
|---|---|---|---|---|---|---|
| 48hC | 48hI | 144hI | 48hCx48hI | 48hIx144hI | ||
| MANI_010527 | 0.54 | 13.59 | 2.67 | 4.51 | −2.27 | Cytochrome P450 |
| MANI_010536 | 8.44 | 36.91 | 1.48 | 2.22 | −4.50 | Transferase family protein |
| MANI_010512 | 4.59 | 25.08 | 0.42 | 2.56 | −5.58 | FAD binding domain-containing |
| MANI_010537 | 3.03 | 30.78 | 4.47 | 3.42 | −2.72 | Transferase family protein |
| MANI_010532 | 0.00 | 12.57 | 0.91 | 6.73 | −3.60 | Cytochrome P450 |
| MANI_010594 | 3.34 | 25.10 | 6.37 | 2.94 | −1.90 | 3-oxoacyl-reductase 1 |
| MANI_010495 | 9.06 | 87.20 | 9.34 | 3.44 | −3.17 | Squalene-hopene-cyclase |
| MANI_010530 | 11.58 | 48.40 | 11.28 | 2.21 | −2.09 | Cytochrome P450 |
| MANI_010531 | 84.51 | 57.83 | 17.62 | NA | −1.67 | Cytochrome P450 |
The relative changes in expression levels were estimated at 48 h for the control condition (hC) and both 48 and 144 h for infection conditions (hI). NA Not Available, ND No Difference